TREM2 and Alzheimer disease: Genetic variants in the human TREM2 gene have been found to increase the risk of developing late-onset AD (Ulland and Colonna, 2018), and plaque–microglial interactions have been studied in human AD patients carrying the most widely studied of these TREM2 variants, designated R47H (Yuan et al., 2016).